[No authors listed] ACOG practice bulletin. Prevention of Rh D alloimmunization. Number 4, May 1999 (replaces educational bulletin Number 147, October 1990). Clinical management guidelines for obstetrician-gynecologists. American College of Obstetrics and Gynecology. Int J Gynaecol Obstet 1999;66:63–70.10.1016/S0020-7292(99)90000-0
Ramsey G; College of American Pathologists Transfusion Medicine Resource Committee. Inaccurate doses of Rh immune globulin after Rh-incompatible fetomaternal hemorrhage: survey of laboratory practice. Arch Pathol Lab Med 2009:133:465–9.10.5858/133.3.46519260751
Hartwell EA. Use of Rh immune globulin: ASCP practice parameter. American Society of Clinical Pathologists. Am J Clin Pathol 1998;110:281–92.10.1093/ajcp/110.3.2819728602
Judd WJ; Scientific Section Coordinating Committee of the AABB. Practice guidelines for prenatal and perinatal immunohematology, revisited. Transfusion 2001;41:1445–52.10.1046/j.1537-2995.2001.41111445.x11724993
Transfusion Medicine Resource Committee. Surveys 2009. HBF-A. Fetal RBC detection. Participant summary. Northfield, IL: College of American Pathologists, 2009.
Bayliss KM, Kueck BD, Johnson ST, et al. Detecting fetomaternal hemorrhage: a comparison of five methods. Transfusion 1991;31:303–7.10.1046/j.1537-2995.1991.31491213292.x1850569
Nossaman JK. Laboratory evaluation of the immunized patient. In: Tregallas WM, Wallas CH, eds. Prenatal and perinatal immunohematology. Chicago, IL: American Association of Blood Banks, 1981:41.
Polesky HF, Sebring ES. Evaluation of methods for detection and quantitation of fetal cells and their effect on RhIgG usage. Am J Clin Pathol 1981;76(4 Suppl):525–9.
Sebring ES. Fetomaternal hemorrhage—incidence and methods of detection and quantitation. In: Garratty G, ed. Hemolytic disease of the newborn. Arlington, VA: American Association of Blood Banks, 1984:87–117.
Harrison KL. Fetal cell counting as an evaluation of Rh prophylaxis with antenatally administered anti-Rh O (D) gamma globulin. Transfusion 1977;17:647–9.10.1046/j.1537-2995.1977.17678075667.x74112
Polesky HF, Sebring ES. Detection of fetal maternal hemorrhage: an evaluation of serological tests related to Rh O (D) immune globulin (human). Transfusion 1971;11:162–5.10.1111/j.1537-2995.1971.tb04396.x
Ness PM. The assessment of fetal-maternal hemorrhage by an enzyme-linked antiglobulin test for Rh immune globulin recipients. Am J Obstet Gynecol 1982;143:788–92.10.1016/0002-9378(82)90011-4
Ness PM, Baldwin ML, Niebyl JR. Clinical high-risk designation does not predict excess fetal-maternal hemorrhage. Am J Obstet Gynecol 1987;156:154–8.10.1016/0002-9378(87)90228-6
Greenwalt TJ, Dumaswala UJ, Domino MM. The quantification of fetomaternal hemorrhage by an enzyme-linked antibody test with glutaraldehyde fixation. Vox Sang 1992;63:268–71.10.1111/j.1423-0410.1992.tb01233.x1481475
Greenwalt TJ, Dumaswala UJ, Siongco A, Domino MM. An enzyme-linked antiglobulin test to detect red cell globulins after glutaraldehyde fixation. Vox Sang 1992;63:262–7.10.1111/j.1423-0410.1992.tb01232.x1481474
Greenwalt TJ, Domino MM, Dumaswala UJ. An enzyme-linked antiglobulin test to quantify nanogram quantities of IgG on polystyrene microspheres. Vox Sang 1992;63:272–5.10.1111/j.1423-0410.1992.tb01234.x1481476
Helderweirt G, Sokal G. Identification, by incomplete sera, of erythrocytes present in trace quantities in blood cell mixtures [in French]. Rev Belg Pathol Med Exp 1960;27:146–57.
Sebring ES, Polesky HF. Rosette test for detection of fetal maternal hemorrhage (letter). Transfusion 1983;23:401–2.10.1046/j.1537-2995.1983.23584018721.x6312645
Taswell HF, Reisner RK. Prevention of Rho hemolytic disease of the newborn: the rosette method—a rapid, sensitive screening test. Mayo Clin Proc 1983;58:342–3.
Salama A, David M, Wittmann G, Stelzer A, Duden-hausen JW. Use of the gel agglutination technique for determination of fetomaternal hemorrhage. Transfusion 1998;38:177–80.10.1046/j.1537-2995.1998.38298193101.x9531950
David M, Stelzer A, Wittmann G, Dudenhausen JW, Salama A. Gel agglutination test—a new test system for semiquantitative detection of feto-maternal transfusion in Rhesus incompatibility [in German]. Z Geburtshilfe Neonatol 1999;203:241–5.
Ben-Haroush A, Belkin A, Chezar J, Orlin J, Hod M, Bar J. Comparison of two techniques of the evaluation of fetomaternal hemorrhage in RhD-negative women: gel agglutination and haemoglobin F determination by flow cytometry. Acta Obstet Gynecol Scand 2007;86:821–6.10.1080/0001634070141550917611827
Agaylan A, Meyer O, Ahrens N, Dudenhausen J, Bombard S, Salama A. A rapid gel agglutination test for the determination of fetomaternal haemorrhage. Transfus Med 2007;17:395–8.10.1111/j.1365-3148.2007.00763.x17903140
Korber E. Cited by H Bischoff. Inaugural Dissertations. Dorpat Ztschr Exp Med 1926;48:472. Cited in package insert, Fetal Hemoglobin Kit 285C, Sigma-Aldrich, revised 2005-01.10.1007/BF02624052
Betke K, Kleihauer E. Fetal and residual hemoglobin in the erythrocytes and erythroblasts of human fetuses and newborn infants [in German]. Blut 1958;4:241–9.10.1007/BF01630321
Shepard MK, Weatherall DJ, Conley CL. Semi-quantitative estimation of the distribution of fetal hemoglobin in red cell populations. Bull Johns Hopkins Hosp 1962;110:293–310.
Boyer SH, Belding TK, Margolet M, Noyes AN, Burke PJ, Bell, WR. Variations in the frequency of fetal hemoglobin-bearing erythrocytes (F-cells) in well adults, pregnant women and adult leukemics. Johns Hopkins Med J 1975;137:105–15.
Cook CD, Brodie HR, Allen DW. Measurement of fetal hemoglobin in newborn infants; correlation with gestational age and intrauterine hypoxia. Pediatrics 1957;20:272–8.10.1542/peds.20.2.272
Clayton EM, Feldaus WD, Phythyon JM. The demonstration of fetal erythrocytes in the presence of adult red blood cells. Am J Clin Pathol 1963;40:487–90.10.1093/ajcp/40.5.487
Clayton EM, Birdwell ED, Gregory MG. Fetal cell counting as a guide to prevention of Rh sensitization. Transfusion 1973;13:425–7.10.1111/j.1537-2995.1973.tb04472.x
Cupp JE, Leary JF, Wood JC, Doherty RA. Rare-event analysis methods for detection of fetal red blood cells in maternal blood. Cytometry 1984;5:138–44.10.1002/cyto.990050207
Medearis AL, Hensleigh PA, Parks DR, Herzenberg LA. Detection of fetal erythrocytes in maternal blood postpartum with the fluorescence-activated cell sorter. Am J Obstet Gynecol 1984;148:290–5.10.1016/S0002-9378(84)80070-8
Ravkin I, Temov V. Automated microscopy system for detection and genetic characterization of fetal nucleated red blood cells on slides. Proc SPIE 1998;3260:180–91.10.1117/12.307091
Pelikan DM, Mesker WE, Scherjon SA, Kanhai HH, Tanke HJ. Improvement of the Kleihauer-Betke test by automated detection of fetal erythrocytes in maternal blood. Cytometry B Clin Cytom 2003;54:1–9.10.1002/cyto.b.10017
Pelikan DM, Scherjon SA, Mesker WE, et al. Quantification of fetomaternal hemorrhage: a comparative study of the manual and automated microscopic Kleihauer-Betke tests and flow cytometry in clinical samples. Am J Obstet Gynecol 2004;191:551–7.10.1016/j.ajog.2004.01.007
Jones P. Assessment of size of small volume fetomaternal bleeds. A new method of quantification of the Kleihauer technique. Br Med J 1969;2:85–8.10.1136/bmj.2.5649.85
Howarth DJ, Robinson FM, Williams M, Norfolk DR. A modified Kleihauer technique for the quantification of foetomaternal haemorrhage. Transfus Med 2002;12:373–8.10.1046/j.1365-3148.2002.00406.x
Creary LE, Ulug P, Menzel S, et al. Genetic variation on chromosome 6 influences F cell levels in healthy individuals of African descent and HbF levels in sickle cell patients. PLoS One 2009;4:e4218.10.1371/journal.pone.0004218
Garner C, Tatu T, Reittie JE, et al. Genetic influences on F cells and other hematologic variables: a twin heritability study. Blood 2000;95:342–6.10.1182/blood.V95.1.342
el-Hazmi MA, Warsy AS, ADar MH, Babae Z. Fetal haemoglobin level—effect of gender, age and haemoglobin disorders. Mol Cell Biochem 1994;135:181–6.10.1007/BF00926521
Popat N, Wood WG, Weatherall DJ, Turnbull AC. Pattern of maternal F-cell production during pregnancy. Lancet 1977;2:377–9.10.1016/S0140-6736(77)90305-1
Lolis D, Georgiou I, Loizou P, Makrydimas G. High HbF in pregnancy is associated with Xmn I polymorphism at the –158bp of the G gamma-globulin gene. Eur J Obstet Gynecol Reprod Biol 1995;60:153–6.10.1016/0028-2243(95)02105-2
Dunn DT, PoDar D, Serjeant BE, Serjeant JR. Fetal haemoglobin and pregnancy in homozygous sickle cell disease. Br J Haematol 1989;72:434–8.10.1111/j.1365-2141.1989.tb07728.x
Lee JC, Hayashi RH, Shepard MK. Fetal hemoglobin in women with normal and with hydatidiform molar pregnancy. Am J Hematol 1982;13:131–9.10.1002/ajh.2830130205
Duguid JKM, Bromilow IM. Laboratory measurement of fetomaternal hemorrhage and its clinical relevance. Transfus Med Rev 1999;13:43–8.10.1016/S0887-7963(99)80087-X
Nance SJ, Nelson JM, Arndt PA, Lam HC, Garratty G. Quantitation of fetal-maternal hemorrhage by flow cytometry. A simple and accurate method. Am J Clin Pathol 1989;91:288–92.10.1093/ajcp/91.3.2882493736
Van Bockstaele D, Berneman ZN, Muylle L, Cole-Dergent J, Peetermans ME. Flow cytometric analysis of erythrocytic D antigen density profile. Vox Sang 1986;51:40–6.10.1159/000461449
Lloyd-Evans P, Kumpel BM, Bromelow I, Austin E, Taylor E. Use of a directly conjugated monoclonal anti-D (BRAD-3) for quantification of fetomaternal hemorrhage by flow cytometry. Transfusion 1996;36:432–7.10.1046/j.1537-2995.1996.36596282587.x8693508
Kumpel BM, MacDonald AP. Quantitation and phenotyping of fetal RBCs in maternal blood by flow cytometry. Transfusion 2003;43:416–17.10.1046/j.1537-2995.2003.00335.x
Greiss MA, Armstrong-Isher SS, Perera WS, Brown PM, Urbaniak SJ. Semiautomated data analysis of flow cytometric estimation of fetomaternal hemorrhage in D– women. Transfusion 2002;42:1067–78.10.1046/j.1537-2995.2002.00159.x
Nelson M, Popp H, Horky K, Forsyth C, Gibson J. Development of a flow cytometric test for the detection of D-positive fetal cells after fetomaternal hemorrhage and a survey of the prevalence in D-negative women. Immunohematology 1994;10:55–9.10.21307/immunohematology-2019-819
Bromilow IM, Dugguid JK. Measurement of fetomaternal haemorrhage: a comparative study of three Kleihauer techniques and two flow cytometry methods. Clin Lab Haematol 1997;19:137–42.10.1046/j.1365-2257.1997.00216.x
Patton WN, Nicholson GS, Sawers AH, Franklin IM, Ala FA, Simpson AW. Assessment of fetomaternal haemorrhage in mothers with hereditary persistence of fetal hemoglobin. J Clin Pathol 1990;43:728–31.10.1136/jcp.43.9.728
Davis BH, Olsen S, Bigelow NC, Chen JC. Detection of fetal red cells in fetomaternal hemorrhage using a fetal hemoglobin monoclonal antibody by flow cytometry. Transfusion 1998;38:749–56.10.1046/j.1537-2995.1998.38898375514.x
Thorpe SJ, Thein SL, Sampietro M, Craig JE, Mahon B, Huehns ER. Immunochemical estimation of haemoglobin types in red blood cells by FACS analysis. Br J Haematol 1994;87:125–32.10.1111/j.1365-2141.1994.tb04881.x
Fernandes BJ, von Dadelszen P, Fazal I, Bansil N, Ryan G. Flow cytometric assessment of feto-maternal hemorrhage; a comparison with Betke-Kleihauer. Prenat Diagn 2007;27:641–3.10.1002/pd.1736
Porra V, Bernaud J, Gueret P, et al. Identification and quantification of fetal red blood cells in maternal blood by a dual-color flow cytometric method: evaluation of the Fetal Cell Count kit. Transfusion 2007;47:1281–9.10.1111/j.1537-2995.2007.01271.x
Radel DJ, Penz CS, Dietz AB, Gastineau DA. A combined flow cytometry-based method for fetomaternal hemorrhage and maternal D. Transfusion 2008;48:1886–91.10.1111/j.1537-2995.2008.01780.x
Chen JC, Bigelow N, Davis BH. Proposed flow cytometric reference method for the determination of erythroid F-cell counts. Cytometry 2000;42:239–46.10.1002/1097-0320(20000815)42:4<;239::AID-CYTO4>3.0.CO;2-Z
National Committee for Clinical Laboratory Standards. Fetal red cell detection: approved guideline. Wayne, PA: National Committee for Clinical Laboratory Standards, 2001:20.
Kennedy GA, Shaw R, Just S, et al. Quantification of feto-maternal haemorrhage (FMH) by flow cytometry: anti-fetal haemoglobin labeling potentially underestimates massive FMH in comparison to labelling with anti-D. Transfus Med 2003;13:25–33.10.1046/j.1365-3148.2003.00416.x
Dziegel MH, Ole K, Berkowicz A. Massive antenatal fetomaternal hemorrhage: evidence for long-term survival of fetal red blood cells. Transfusion 2005;45:539–44.10.1111/j.0041-1132.2005.04262.x
Navenot JM, Merghoub T, Ducrocq R, Muller JY, Krishnamoorthy R, Blanchard D. New method for quantitative determination of fetal hemoglobin-containing red blood cells by flow cytometry: application to sickle-cell disease. Cytometry 1998;32:186–90.10.1002/(SICI)1097-0320(19980701)32:3<;186::AID-CYTO4>3.0.CO;2-I
Italia KY, Colah R, Mohanty D. Evaluation of F cells in sickle cell disorders by flow cytometry—comparison with the Kleihauer-Betke’s slide method. Int J Lab Hematol 2007;29:409–14.10.1111/j.1365-2257.2006.00884.x
Amoyal I, Fibach E. Flow cytometric analysis of fetal hemoglobin in erythroid precursors of beta-thalassemia. Clin Lab Haematol 2004;26:187–93.10.1111/j.1365-2257.2004.00606.x
Ness P, Salamon JL. The failure of postinjection Rh immune globulin titers to detect large fetal-maternal hemorrhages. Am J Clin Pathol 1986;85:604–6.10.1093/ajcp/85.5.604
Herzenberg LA, Parks D, Sahaf B, Perez O, Roederer M, Herzenberg LA. The history and the future of the fluorescence activated cell sorter and flow cytometry: a view from Stanford. Clin Chem 2002;48:1819–27.10.1093/clinchem/48.10.1819